Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Elutia Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 24 | 17 | −7 |
| Shares | 2.05M | 1.90M | −152.8K (−7.5%) |
| Value | $19.7M | $13.2M | −$6.49M (−32.9%) |
New holders (1)
Institutions that held Elutia Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 181 | $1.00K | 0.00% |
Sold out (8)
Institutions that held Elutia Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| RTW Investments, LP | 125,000 | $1.20M |
| Walleye Capital LLC | 83,253 | $800.0K |
| Ergoteles LLC | 10,000 | $96.0K |
| O'Shaughnessy Asset Management, LLC | 2,871 | $28.0K |
| JPMorgan Chase & Co | 1,687 | $16.0K |
| New York State Common Retirement Fund | 15 | $0 |
| Citigroup Inc | 1 | $0 |
| Royal Bank of Canada | 33 | $0 |